Hepatoprotective effect of pentoxifylline against D-galactosamine-induced hepatotoxicity in rats

Annals of Hepatology

Volumn 8, Issue 4, 2009, Pages 364-370

  Taye, Ashraf ^a   El Moselhy, Mohamed A ^a   Hassan, Magdy K A ^b   Ibrahim, Hanaa M ^b   Mohammed, Aliaa F ^a  

^a Minia University   (Egypt)

^b Minia University   (Egypt)

Author keywords

Antioxidant; D galactosamine; Hepatotoxicty; Pentoxifylline

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CATALASE; GALACTOSAMINE; MALONALDEHYDE; NITRITE; PENTOXIFYLLINE; SILYMARIN; SUPEROXIDE DISMUTASE; LIPID PEROXIDE; PHOSPHODIESTERASE INHIBITOR; PROTECTIVE AGENT; SERUM ALBUMIN;

ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVITY; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER FUNCTION TEST; LIVER PROTECTION; LIVER TOXICITY; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; TOXIC HEPATITIS; VASCULITIS; ANIMAL; BLOOD; DISEASE MODEL; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER; METABOLISM; PATHOLOGY; RAT STRAIN;

ALKALINE PHOSPHATASE; ANIMALS; CATALASE; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; GALACTOSAMINE; INJECTIONS, INTRAPERITONEAL; LIPID PEROXIDES; LIVER; MALE; MALONDIALDEHYDE; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; PROTECTIVE AGENTS; RATS; RATS, INBRED STRAINS; SERUM ALBUMIN; SILYMARIN; SUPEROXIDE DISMUTASE;

EID: 77953462213     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31751-x     Document Type: Article

References (42)

1. Sugiyama K, He P, Wada S, Saeki S. Teas and other beverages suppress D-galactosamine-induced liver injury in rats. J Nutr 1999; 129(7): 1361-1367.
2. Wills PJ, Asha VV. Protective effect of Lygodium flexuo-sum (L.) Sw. (Lygodiaceae) against D-galactosamine induced liver injury in rats. J Ethnopharmacol 2006; 108(1): 116-123.
3. Jonker AM, Dijkhuis FW, Boes A, Hardonk MJ, Grond J. Im-munohistochemical study of extracellular matrix in acute galactosamine hepatitis in rats. Hepatology 1992; 15(3): 423-431.
4. Keppler DO, Pausch J, Decker K. Selective uridine triphos-phate deficiency induced by D-galactosamine in liver and reversed by pyrimidine nucleotide precursors. Effect on ribonucleic acid synthesis. J Biol Chem 1974; 249(1): 211-216.
5. Fischer W, Schudt C, Wendel A. Protection by phospho-diesterase inhibitors against endotoxin-induced liver injury in galactosamine-sensitized mice. Biochem Pharmacol 1993; 45(12): 2399-404.
6. Taguchi I, Oka K, Kitamura K, Sugiura M, Oku A, Matsumo-to M. Protection by a cyclic AMP-specific phosphodieste-rase inhibitor, rolipram, and dibutyryl cyclic AMP against Propionibacterium acnes and lipopolysaccharide-induced mouse hepatitis. Inflamm Res 1999; 48(7): 380-385.
7. Thompson MK, Tuma RF, Young WF. The effects of pentoxi-fylline on spinal cord blood flow after experimental spinal cord injury. J Assoc Acad Minor Phys 1999; 10(1): 23-26.
8. Feher J, Lang I, Nekam K, Gergely P, Muzes G. In vivo effect of free radical scavenger hepatoprotective agents on superoxide dismutase (SOD) activity in patients. Tokai J Exp Clin Med 1990; 15(2-3): 129-134.
9. Faulstich H, Jahn W, Wieland T. Silybin inhibition of ama-toxin uptake in the perfused rat liver. Arzneimittelfors-chuns 1980; 30(3): 452-454.
10. Abdel-Salam OM, Baiuomy AR, El-Shenawy SM, Arbid MS. The anti-inflammatory effects of the phosphodiesterase inhibitor pentoxifylline in the rat. Pharmacol Res 2003; 47(4): 331-340.
11. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-310.
12. Babizhayev MA, Costa EB. Lipid peroxide and reactive oxygen species generating systems of the crystalline lens. Biochimica et biophysica acta 1994; 1225(3): 326-337.
13. Yoo YM, Nam JH, Kim MY, Choi J, Park HJ. Pectolinarin and Pectolinarigenin of Cirsium setidens Prevent the Hepatic Injury in Rats Caused by D-Galactosamine via an Antioxi-dant Mechanism. Biol Pharm Bull 2008; 31(4): 760-764.
14. Sonnenbichler J, Zetl I. Biochemical effects of the flavono-lignane silibinin on RNA, protein and DNA synthesis in rat livers. Pros Clin Biol Res 1986; 213: 319-331.
15. Kropacova K, Misurova E, Hakova H. Protective and therapeutic effect of silymarin on the development of latent liver damage. Radiats Biol Radioecol 1998; 38(3): 411-415.
16. Muriel P, Mourelle M. Prevention by silymarin of membrane alterations in acute CCl4 liver damage. J Appl Toxicol 1990; 10(4): 275-279.
17. Chrungoo VJ, Singh K, Singh J. Silymarin mediated differential modulation of toxicity induced by carbon tetra-chloride, paracetamol and D-galactosamine in freshly isolated rat hepatocytes. Indian J Exp Biol 1997; 35(6): 611-617.
18. Conti M, Malandrino S, Magistretti MJ. Protective activity of silipide on liver damage in rodents. Jpn J Pharmacol 1992; 60(4): 315-320.
19. Wong MC, Portmann B, Sherwood R, Niemela O, Koivisto H, et al. The cytoprotective effect of alpha-tocopherol and daidzein against d-galactosamine-induced oxidative damage in the rat liver. Metabolism 2007; 56(7): 865-875.
20. Dabeva MD, Shafritz DA. Activation, proliferation, and differentiation of progenitor cells into hepatocytes in the D-galactosamine model of liver regeneration. Am J Pathol 1993; 143(6): 1606-1620.
21. Peterson TC. Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor-driven proliferation of fibroblasts. Hepatolosy 1993; 17(3): 486-493.
22. Kumar P, Nagpaul JP, Singh B, Bansal RC, Sharma R. Nature of inhibition of rat testicular alkaline phosphatase by isatin. Experientia 1978; 34(4): 434-435.
23. Abdel SOM, Baiuomy AR, El-Shenawy SM, Hassan NS. Effect of pentoxifylline on hepatic injury caused in the rat by the administration of carbon tetrachloride or acetaminophen. Pharmacol Rep. Sep-Oct 2005; 57(5): 596-603.
24. Kattermann R, Sirowej H. Liver injury and lipid metabolism: sex differences in the fatty liver induced by d-galactosamine. Acta Hepatosastroenterol (Stutts) 1979; 2(26): 112-126.
25. Di Sario A, Bendia E, Taffetani S, Omenetti A, Candelaresi C, Marzioni M, et al. Hepatoprotective and antifibrotic effect of a new silybin-phosphatidylcholine-Vitamin E complex in rats. Dis Liver Dis 2005; 37(11): 869-876.
26. El-Sherbiny GA, Taye A, Abdel-Raheem IT. Role of ursodeoxycholic acid in prevention of hepatotoxicity caused by amoxicillin-clavulanic acid in rats. Ann Hepatol 2009; 8(2): 134-140.
27. Li X, Liu Y, Song L, Liu J. Responses of antioxidant systems in the hepatocytes of common carp (Cyprinus carpio L.) to the toxicity of microcystin-LR. Toxicon 2003; 42(1): 85-89.
28. Jaeschke H. Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol. J Pharmacol Exp Ther 1990; 255(3): 935-941.
29. Shiratori Y, Kawase T, Shiina S, Okano K, Sugimoto T, Te-raoka H, et al. Modulation of hepatotoxicity by macrophages in the liver. Hepatolosy 1988; 8(4): 815-821.
30. Hu HL, Chen RD. Changes in free radicals, trace elements, and neurophysiological function in rats with liver damage induced by D-galactosamine. Biol Trace Elem Res 1992; 34(1): 19-25.
31. De Bleser PJ, Xu G, Rombouts K, Rogiers V, Geerts A. Glu-tathione levels discriminate between oxidative stress and transforming growth factor-beta signaling in activated rat hepatic stellate cells. J Biol Chem 1999; 274(48): 33881-33887.
32. Pastor A, Collado PS, Almar M, Gonzalez-Gallego J. Antioxidant enzyme status in biliary obstructed rats: effects of N-acetylcysteine. J Hepatol 1997; 27(2): 363-370.
33. Bai J, Cederbaum AI. Adenovirus-mediated overexpression of catalase in the cytosolic or mitochondrial compartment protects against cytochrome P450 2E1-dependent toxici-ty in HepG2 cells. J Biol Chem 2001; 276(6): 4315-4321.
34. Toyama T, Nakamura H, Harano Y, Yamauchi N, Morita A, Kirishima T, et al. PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats. Biochem Biophys Res Commun 2004; 324(2): 697-704.
35. Anandan R, Devaki, T. Hepatoprotective effect of Picrorr-hiza kurroa on tissue defence system in-galactosamine-in-duced hepatitis in rats. Fitoterapia 1999; 70(1): 54-57.
36. Meena B, Anbin ER, Rajesh R, Sheik HA, Ganesan B, Anandan R. Antihepatotoxic potential of Sargassum polycystum (Phaeophyceae) on antioxidant defense status in Dgalac-tosamine-induced hepatitis in rats. Afr J Biochem Res 2008; 2(2): 51-55.
37. Vimal V, Devaki T. Hepatoprotective effect of allicin on tissue defense system in galactosamine/endotoxin challenged rats. J Ethnopharmacol 2004; 90(1): 151-154.
38. Abdollahi M, Fooladian F, Emami B, Zafari K, Bahreini-Moghadam A. Protection by sildenafil and theophylline of lead acetate-induced oxidative stress in rat sub-mandibular gland and saliva. Hum Exp Toxicol 2003; 22(11): 587-592.
39. Demir S, Inal-Erden M. Pentoxifylline and N-acetylcysteine in hepatic ischemia/reperfusion injury. Clin Chim Acta 1998; 275(2): 127-135.
40. Savas S, Delibas N, Savas C, Sutcu R, Cindas A. Pentoxify-lline reduces biochemical markers of ischemia-reperfusion induced spinal cord injury in rabbits. Spinal Cord 2002; 40(5): 224-229.
41. Sass G, Koerber K, Bang R, Guehring H, Tiegs G. Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. J Clin Invest 2001; 107(4): 439-447.
42. Li J, Billiar TR. Nitric Oxide. IV. Determinants of nitric oxide protection and toxicity in liver. Am J Physiol 1999; 276(5 Pt 1): G1069-G1073.